Document is current
Any future updates will be listed below
-
Authors
Ferré, Valentine M.
Sadio, Arnold J.
Gbeasor-Komlanvi, Fifonsi A.
Bucau, Margot
Salou, Mounerou
Berçot, Béatrice
Bébéar, Cécile
Abramowitz, Laurent
Zaidi, Meryem
Amenyah-Ehlan, Amivi P.
Mensah, Ephrem
Braille, Aymeric
Couvelard, Anne
Dagnra, Anoumou C.
Ghosn, Jade
Descamps, Diane
Charpentier, Charlotte
Ekouevi, Didier K.
-
Funding
Funding for this research was provided by:
Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 7 July 2025
First Online: 26 September 2025
Declarations
:
: The study involved human participants, and the protocol was approved by all participants, who provided written informed consent. The Bioethics Committee of the Ministry of Health in Togo (CBRS) approved the study protocol (N°039/2019/CBRS), and the study was registered on the ClinicalTrial.gov platform with the number NCT04910438.
: Not applicable.
: C.C., J.G., and D.D. have received honoraria and travel grants for conferences from MSD, Gilead Sciences, and ViiV Healthcare. VMF has received honoraria and/or travel grants for conferences from AstraZeneca, Moderna, Copan, and Gilead. The other authors declare that they have no competing interests.
